Plain-English translation of NCT05200650 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new treatment called TumoCure, which is a special gel containing the chemotherapy drug cisplatin that is injected directly into a head and neck tumor. The medication is designed to deliver cancer-fighting medicine right where it's needed, in one single injection. The study wants to see if this approach is safe and effective for patients whose cancers have stopped responding to standard treatments.
Many patients with head and neck cancer find that standard treatments like chemotherapy and radiation stop working or cause serious side effects. This medication offers a new option by delivering treatment directly to the tumor in a single dose, which may help patients who have run out of other choices.
You likely qualify if…
You likely don't qualify if…
You will receive a single injection of the medication directly into your tumor. The study will then monitor you to watch for any side effects and to see how well the treatment works. You'll likely have follow-up visits and imaging scans to measure your tumor's response. This is a Phase 1 trial, which means researchers are primarily focused on learning about safety and tolerability while also gathering early information about effectiveness.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Israel